X @The Wall Street Journal

From @WSJopinion: Eli Lilly and Novo Nordisk are trying to transform how patients access medication, and Washington has done its part. It’s time to let consumers roar into a competitive marketplace—without government intervention, writes Stephen Buck. https://t.co/OKYWoEYHl1 ...